Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIα and proliferating cell nuclear antigen expression in lung cancer

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2357-2362

  Gu, C ^a   Oyama, T ^a   Osaki, T ^a   Kohno, K ^a   Yasumoto, K ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cell proliferation; Drug resistance; Lung cancer; YB 1

Indexed keywords

CYCLINE; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II ALPHA; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CCAAT-ENHANCER-BINDING PROTEINS; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; NFI TRANSCRIPTION FACTORS; P-GLYCOPROTEIN; PROLIFERATING CELL NUCLEAR ANTIGEN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; Y-BOX-BINDING PROTEIN 1;

EID: 0035149485     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. DNA topoisomerase
2. Current status of etoposide in the management of small cell lung cancer
3. Etoposide in the management of non-small cell lung cancer
4. Identity of the proliferating cell nuclear antigen and cyclin
5. Cyclin/ PCNA is the auxiliary protein of DNA polymerase-delta
6. Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer. Relation to cisplatin sensitivity
7. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy
8. Proliferating cell nuclear antigen as a predictor of therapeutic effect of continuous 5-fluorouracil administration in gastric cancer
9. MDR 1 gene expression in lung cancer
10. The Y-box factors: A family of nucleic acid binding proteins conserved from Escherichia coli to man
11. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins
12. A role for Y-box proteins in cell proliferation
13. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light
14. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
15. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene
16. Revisions in the international system for staging lung cancer
17. Enhanced coexpression of YB-1 and DNA topoisomerase IIa genes in human colorectal carcinomas
18. Immunohistochemical detection of DNA topoisomerase II alpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer
19. Expression of DNA topoisomerase IIα and Topoisomerase IIβ genes predicts survival and respose to chemotherapy in patients with small cell lung cancer
20. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression
21. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer
22. Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes
23. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation
24. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression
25. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma
26. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
27. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression
28. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC 4
29. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas
30. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?